secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2021-11-23T23:59:59+00:00
Accession:  0001193125-21-337594
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma appoints Sujay Kango to board; Kevan Clemens resigns effective Nov 22, 2021
--------------------------------------------------------------------------------

- Kevan Clemens resigned from board effective Nov 22, 2021; no disagreement with company.
- Sujay Kango appointed to fill vacancy; 25+ years pharma/biotech experience.
- Kango received initial option grant of 25,000 shares vesting over three years.
- Kango also received pro-rated annual option grant of 33,334 shares vesting monthly over 12 months.
- Kango's expertise includes commercial launches; company aims to transition to commercial stage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/0001193125-21-337594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/d261318d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-337594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer